Concepedia

Publication | Closed Access

Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma

DOI

10

Citations

0

References

2020

Year

Umang Swami, Benjamin Haaland, Adam Kessel, Roberto Nussenzveig, Benjamin L. Maughan, John Esther, Deepika Sirohi, Sumanta K. Pal, Petros Grivas, Neeraj Agarwal
The Journal of Urology

Abstract

In this large real-world cohort, effectiveness in terms of time to initiation of third therapy or death and overall survival with programmed cell death protein 1/L1 inhibitors in patients with platinum refractory locally advanced/unresectable or metastatic urothelial carcinoma was similar.